{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:45:18Z","timestamp":1793825118855,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.vaccine.2017.04.052","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T00:33:27Z","timestamp":1498782807000},"page":"4287-4294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus"],"prefix":"10.1016","volume":"35","author":[{"given":"Ming","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.04.052_b0005","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1128\/JVI.00252-16","article-title":"Zika virus: new clinical syndromes and its emergence in the western hemisphere","volume":"90","author":"Lazear","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.04.052_b0010","doi-asserted-by":"crossref","unstructured":"Attar N. ZIKA virus circulates in new regions. Nat Rev Micro 2016;14:62.","DOI":"10.1038\/nrmicro.2015.28"},{"key":"10.1016\/j.vaccine.2017.04.052_b0015","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2017.04.052_b0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(16)00257-9","article-title":"Concern over Zika virus grips the world","volume":"387","author":"Samarasekera","year":"2016","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2017.04.052_b0025","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2017.04.052_b0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.04.052_b0035","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1128\/JVI.01087-10","article-title":"Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2","volume":"84","author":"Sukupolvi-Petty","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.04.052_b0040","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","article-title":"Structural basis of Zika virus-specific antibody protection","volume":"166","author":"Zhao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2017.04.052_b0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4269\/ajtmh.2005.72.189","article-title":"Randomized, double-blind, phase III. Pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (ARILVAX\u2122 and YF-VAX\u00ae) in healthy infants and children in Peru","volume":"72","author":"Belmusto-Worn","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.04.052_b0050","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.052_b0055","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/pbi.12217","article-title":"Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants","volume":"12","author":"Lai","year":"2014","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2017.04.052_b0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1155\/2014\/952865","article-title":"A plant-produced antigen elicits potent immune responses against West Nile virus in mice","volume":"2014","author":"He","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2017.04.052_b0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-7652.2011.00649.x","article-title":"Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce","volume":"10","author":"Lai","year":"2012","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2017.04.052_b0070","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.vaccine.2008.01.053","article-title":"An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles","volume":"26","author":"Santi","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.052_b0080","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1099\/jgv.0.000635","article-title":"Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity","volume":"97","author":"Dent","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.04.052_b0085","doi-asserted-by":"crossref","unstructured":"Jungblut M, Oeltze K, Zehnter I, Hasselmann D, Bosio A. Preparation of Single-Cell Suspensions from Mouse Spleen with the gentleMACS Dissociator; 2008:e1029.","DOI":"10.3791\/1029"},{"key":"10.1016\/j.vaccine.2017.04.052_b0090","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1073\/pnas.0914503107","article-title":"Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice","volume":"107","author":"Lai","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2017.04.052_b0095","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","article-title":"Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes","volume":"78","author":"Crill","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.04.052_b0100","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.04.052_b0105","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.04.052_b0110","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.052_b0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2249.1997.4311446.x","article-title":"Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages","volume":"110","author":"Kreil","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2017.04.052_b0120","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/AEM.25.4.539-544.1973","article-title":"Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine","volume":"25","author":"Mason","year":"1973","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.vaccine.2017.04.052_b0125","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.4049\/jimmunol.1000768","article-title":"TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis","volume":"185","author":"Demento","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.04.052_b0130","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4155\/tde.11.68","article-title":"Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems","volume":"2","author":"Foged","year":"2011","journal-title":"Therap Deliv"},{"key":"10.1016\/j.vaccine.2017.04.052_b0135","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1038\/sj.bjc.6601888","article-title":"Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)","volume":"90","author":"Mayer","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2017.04.052_b0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4269\/ajtmh.2004.71.239","article-title":"Update on the clinical development of candidate malaria vaccines","volume":"71","author":"Ballou","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.04.052_b0145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/clinids\/19.3.500","article-title":"Antibody-dependent of enhancement of infection and the pathogenesis of viral disease","volume":"19","author":"Morens","year":"1994","journal-title":"Clin Inf Dis"},{"key":"10.1016\/j.vaccine.2017.04.052_b0150","doi-asserted-by":"crossref","unstructured":"Halstead SB. Dengue antibody-dependent enhancement: knowns and unknowns. Microbiology spectrum; 2014:2.","DOI":"10.1128\/microbiolspec.AID-0022-2014"},{"key":"10.1016\/j.vaccine.2017.04.052_b0155","doi-asserted-by":"crossref","unstructured":"Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol; 2016 [advance online publication].","DOI":"10.1038\/ni.3515"},{"key":"10.1016\/j.vaccine.2017.04.052_b0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika\u2013dengue virus antibody cross-neutralization","volume":"536","author":"Barba-Spaeth","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.04.052_b0165","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.04.052_b0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 \u00c5 resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.04.052_b0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2017.04.052_b0180","doi-asserted-by":"crossref","first-page":"e1447","DOI":"10.1371\/journal.pntd.0001447","article-title":"Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay","volume":"6","author":"Lin","year":"2012","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T06:51:02Z","timestamp":1602399062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17305443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":35,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0264410X17305443"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}